NPPB and hydrops fetalis: Currently, the clinical introduction of testing for troponins and BNP/NT-proBNP has fueled interest in the utilization of other putative HF biomarkers listed under the categories of neurohormonal activation, myocardial overload, cardiac injury and cardiac remodeling in Table 3.